Company / Total Debt
AMICUS THERAPEUTICS, INC. Total Debt History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Total Debt
$392.7M
FY2025
5-year range
$387.9M / $392.7M
FY2021-FY2025
Trend
+0.7%
vs FY2024
Sector context
#31 of 83
Health Care
What the data says
At $393M, AMICUS THERAPEUTICS, INC.'s total debt ranks #53 of 83 in the Health Care sector.
Based on SEC 10-K filings.
$393M in FY2025 with a 5-year CAGR of +0.2%.
Remained stable around $393M over the past 2 years.
Health Care sector context is included.
Total Debt over time
Growth rates
- 3-Year CAGR
- +0.1%
- 5-Year CAGR
- +0.2%
- 10-Year CAGR
- -
Sector benchmark
#53 of 83 in Health CareTop 63% of 83This company $392.7M Sector average $6.2B
▼
-93.6% below sector average
Key checks
Key Insights
- 5-year CAGR of +0.2%, indicating consistent growth.
- In FY2025, total debt increased 0.7% year-over-year.
- Ranks #31 out of 83 companies in the Health Care sector.
- Lowest total debt in the period was in FY2019.
Company context
Key Data Points
- Altman Z-Score -1.19 (distress zone, below 1.8 threshold)
- Negative profit margin: -10.6%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Total DebtValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $392.7M | +0.7% |
| FY2024 | $390.1M | +0.6% |
| FY2023 | $387.9M | -1.1% |
| FY2022 | $392.0M | +0.7% |
| FY2021 | $389.4M | +0.0% |
| FY2020 | $389.3M | +160.4% |
| FY2019 | $149.5M | - |
| FY2018 | - | - |
| FY2017 | - | - |
| FY2016 | - | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026